Literature DB >> 17954190

Epidemiology and risk factors for corneal graft rejection.

D Sellami1, S Abid, G Bouaouaja, S Ben Amor, B Kammoun, M Masmoudi, K Dabbeche, H Boumoud, Z Ben Zina, J Feki.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the frequency and main risk factors for corneal graft rejection. PATIENTS AND METHODS: This retrospective study included 285 eyes in 256 patients who underwent a penetrating keratoplasty (KPT) from January 1995 to December 2004. The minimum follow-up was 12 months to evaluate graft evolution. Except for complications, the follow-up was weekly, then monthly for 6 months, and ultimately quarterly during the first year. Thereafter the follow-up was performed semi-annually. Patients were informed about the functional signs for which they have to urgently consult.
RESULTS: Immunologic rejection of the corneal graft occurred in 128 KPT in 112 patients (rejection frequency = 41%). The identified main risk factors were new vascularization of the recipient cornea over 2 or more quadrants, corneal opacity due to an infectious origin, posttraumatic corneal opacity or congenital glaucoma, graft diameter >8 mm, and therapeutic KPT.
CONCLUSIONS: Rejection of the corneal graft is the primary cause of KPT failure. One out of 2 graft failures was due to rejection. Two criteria are unanimously recognized as risk factors for rejection: neovascularization of recipient cornea and antecedents of corneal rejection. The rejection must be treated early to not endanger graft success, which imposes a close follow-up for grafted patients.

Entities:  

Mesh:

Year:  2007        PMID: 17954190     DOI: 10.1016/j.transproceed.2007.08.020

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  17 in total

1.  A retrospective clinical study of Xinjiang Uygur patients with corneal allograft rejection.

Authors:  Reziwan Maimaitiming; Xin Yang; Kelala Wupuer; Nan Ye; Na Kong; Baoyu Gu; Yuanyuan Fan; Lan Shao; Zhiqiang Pan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Efficacy of topical bevacizumab in high-risk corneal transplant survival.

Authors:  Nasir Bhatti; Umair Qidwai; Munawar Hussain; Asif Kazi
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

3.  Cryopreserved limbal lamellar keratoplasty for peripheral corneal and limbal reconstruction.

Authors:  Hua-Tao Xie; Jing Li; Yang Liu; Dong-Ling Jiang; Rui-Fen Shen; Ming-Chang Zhang
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

4.  Unusual case of globe perforation: the brittle cornea without systemic manifestations.

Authors:  Shilpa Ajit Joshi; Shalomith Uppapalli; Pranav More; Madan Deshpande
Journal:  BMJ Case Rep       Date:  2016-10-07

5.  S100A proteins in the pathogenesis of experimental corneal neovascularization.

Authors:  Changyou Li; Feng Zhang; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-10-31       Impact factor: 2.367

6.  Evaluation of corneal graft survival in mice model.

Authors:  Guo-Ling Chen; Jing-Jing Zhang; Jun Zhao; Da-Jiang Wang; Han Zhang
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

7.  Nerves and neovessels inhibit each other in the cornea.

Authors:  Giulio Ferrari; Amir R Hajrasouliha; Zahra Sadrai; Hiroki Ueno; Sunil K Chauhan; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-28       Impact factor: 4.799

8.  Tissue and cellular characterisation of nucleolin in a murine model of corneal angiogenesis.

Authors:  Joaquín Quiroz-Mercado; Norma Ramírez-Velázquez; Graciela Partido; Edgar Zenteno; Raúl Chávez; Concepción Agundis-Mata; Maria Carmen Jiménez-Martínez; Yonathan Garfias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-16       Impact factor: 3.117

Review 9.  Novel aspects of corneal angiogenic and lymphangiogenic privilege.

Authors:  David Ellenberg; Dimitri T Azar; Joelle A Hallak; Faisal Tobaigy; Kyu Yeon Han; Sandeep Jain; Zhongjun Zhou; Jin-Hong Chang
Journal:  Prog Retin Eye Res       Date:  2010-01-25       Impact factor: 21.198

10.  Effects of rat anti-VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival routes.

Authors:  Nicolas Rocher; Francine Behar-Cohen; Jean-Antoine C Pournaras; Marie-Christine Naud; Jean-Claude Jeanny; Laurent Jonet; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2011-01-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.